Apellis Pharmaceuticals shares owned by Assetmark
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Assetmark
from 13F filings
Historical chart of Assetmark investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Assetmark consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Assetmark
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.3M | 46k | 28.84 |
| 2024-06-30 | $1.7M | 43k | 38.36 |
| 2024-03-31 | $1.3M | 22k | 58.78 |
| 2023-12-31 | $1.0M | 17k | 59.86 |
| 2023-09-30 | $433k | 11k | 38.04 |
| 2023-06-30 | $549k | 6.0k | 91.10 |
| 2023-03-31 | $317k | 4.8k | 65.96 |